Literature DB >> 35852684

Effect of Repetitive Transcranial Magnetic Stimulation on Serum Levels of Steroid Adrenal Hormones in Parkinson's Disease: Sex Differences.

L I Aftanas1, S Ya Zhanaeva2, E L Al'perina1, G V Idova1, M M Gevorgyan1, S S Dzemidovich1, K I Kulikova1.   

Abstract

In a parallel placebo-controlled study, we examined the effect of repetitive transcranial magnetic stimulation (rTMS) on serum concentrations of cortisol and dehydroepiandrosteron sulfate (DHEAS), and their relationships with clinical symptoms in men and women with Parkinson's disease. A 20-day course of real rTMS reduced the UPDRS and UPDRS III scores in patients with Parkinson's disease in comparison with the basal parameters (before rTMS), regardless of their sex. The level of cortisol did not change in men and women; at the same time, the content of DHEAS in men increased and before rTMS negatively correlated with the UPDRS scores. Sham rTMS had no effects on clinical parameters or hormonal levels. Possible mechanisms of sex-dependent differences in the effect of rTMS on the level of the neurosteroid hormone DHEAS are discussed.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Parkinson’s disease; cortisol; dehydroepiandrosterone sulfate (DHEAS); repetitive transcranial magnetic stimulation (rTMS); sex differences

Mesh:

Substances:

Year:  2022        PMID: 35852684     DOI: 10.1007/s10517-022-05542-y

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  13 in total

Review 1.  Dehydroepiandrosterone sulphate: action and mechanism in the brain.

Authors:  Y Dong; P Zheng
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

2.  Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson's Disease: a Placebo-Controlled Study.

Authors:  L I Aftanas; M M Gevorgyan; S Ya Zhanaeva; S S Dzemidovich; K I Kulikova; E L Al'perina; K V Danilenko; G V Idova
Journal:  Bull Exp Biol Med       Date:  2018-06-19       Impact factor: 0.804

Review 3.  Parkinson disease.

Authors:  R Balestrino; A H V Schapira
Journal:  Eur J Neurol       Date:  2019-11-27       Impact factor: 6.089

Review 4.  Dehydroepiandrosterone Research: Past, Current, and Future.

Authors:  Carolyn M Klinge; Barbara J Clark; Russell A Prough
Journal:  Vitam Horm       Date:  2018-03-16       Impact factor: 3.421

5.  Systematic review of biological markers of therapeutic repetitive transcranial magnetic stimulation in neurological and psychiatric disorders.

Authors:  Helena K Kim; Daniel M Blumberger; Jonathan Downar; Zafiris J Daskalakis
Journal:  Clin Neurophysiol       Date:  2020-12-16       Impact factor: 3.708

6.  The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients.

Authors:  C Baeken; R De Raedt; L Leyman; J Schiettecatte; L Kaufman; K Poppe; M A Vanderhasselt; E Anckaert; A Bossuyt
Journal:  J Affect Disord       Date:  2008-06-24       Impact factor: 4.839

7.  Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation.

Authors:  Ettore Accolla; Elena Caputo; Filippo Cogiamanian; Filippo Tamma; Simona Mrakic-Sposta; Sara Marceglia; Marcello Egidi; Paolo Rampini; Marco Locatelli; Alberto Priori
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

Review 8.  Sex differences in Parkinson's disease.

Authors:  Glenda E Gillies; Ilse S Pienaar; Shiv Vohra; Zahi Qamhawi
Journal:  Front Neuroendocrinol       Date:  2014-03-04       Impact factor: 8.606

Review 9.  Parkinson's Disease in Women and Men: What's the Difference?

Authors:  Silvia Cerri; Liudmila Mus; Fabio Blandini
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

10.  rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex.

Authors:  Sang Soo Cho; Antonio P Strafella
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.